Drugs / DA-2902-R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07239453 | Nov 2025 | infectious disease | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-2902-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07239453 ↗ |
| Route | Oral | “Single Oral Dose” NCT07239453 ↗ |